Cargando…

Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia

Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by Clostridium perfringens enterotoxin (CPE) leads to activation of the transcriptional co-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara-Tani, Rina, Fujii, Kiyomu, Mori, Shiori, Kishi, Shingo, Sasaki, Takamitsu, Ohmori, Hitoshi, Nakashima, Chie, Kawahara, Isao, Nishiguchi, Yukiko, Mori, Takuya, Sho, Masayuki, Kondoh, Masuo, Luo, Yi, Kuniyasu, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313056/
https://www.ncbi.nlm.nih.gov/pubmed/32481659
http://dx.doi.org/10.3390/ijms21113840
_version_ 1783549871032107008
author Fujiwara-Tani, Rina
Fujii, Kiyomu
Mori, Shiori
Kishi, Shingo
Sasaki, Takamitsu
Ohmori, Hitoshi
Nakashima, Chie
Kawahara, Isao
Nishiguchi, Yukiko
Mori, Takuya
Sho, Masayuki
Kondoh, Masuo
Luo, Yi
Kuniyasu, Hiroki
author_facet Fujiwara-Tani, Rina
Fujii, Kiyomu
Mori, Shiori
Kishi, Shingo
Sasaki, Takamitsu
Ohmori, Hitoshi
Nakashima, Chie
Kawahara, Isao
Nishiguchi, Yukiko
Mori, Takuya
Sho, Masayuki
Kondoh, Masuo
Luo, Yi
Kuniyasu, Hiroki
author_sort Fujiwara-Tani, Rina
collection PubMed
description Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by Clostridium perfringens enterotoxin (CPE) leads to activation of the transcriptional co-activator yes-associated protein (YAP) in oral squamous cell carcinoma. Here, we investigated whether CPE activates YAP to promote the malignant progression of SSA/P. E-cadherin expression was lower in the 12 cases with SSA/P-D examined than that in normal mucosa, SSA/P, or tubular adenoma (TA). Furthermore, intracellular translocation of claudin-4 (CLDN4) and nuclear translocation of YAP were observed. The CPE gene was detected in DNA extracted from SSA/P-D lesions, but not in SSA/P or TA. Treatment of the rat intestinal epithelial cell line IEC6 with low-dose CPE resulted in intracellular translocation of CLDN4 to the cytoplasmic membrane. Cytoplasmic CLDN4 showed co-precipitation with transcriptional co-activator with PDZ-binding motif, zonula occludens (ZO)-1, large tumor suppressor, and mammalian Ste20-like. Additionally, YAP co-precipitated with ZO-2 under CPE treatment led to decreased YAP phosphorylation and nuclear translocation. YAP activation promoted increase in nuclear TEA domain family member level, expression of cyclin D1, snail, vimentin, CD44, NS and decrease in E-cadherin levels, thereby inducing stemness and epithelial-mesenchymal-transition (EMT). The Hippo complex with the incorporation of CLDN4 increased stability. Upon low-dose CPE treatment, HT29 cells with BRAF(V600E) gene mutation showed increased growth, enhanced invasive potential, stemness, and induced EMT phenotype, whereas HCT116 cells, which carry KRAS(G13D) gene mutation, did not show such changes. In an examination of 10 colorectal cancers, an increase in EMT and stemness was observed in CPE (+) and BRAF mutation (+) cases. These findings suggest that C. perfringens might enhance the malignant transformation of SSA/P-D via YAP activation. Our findings further highlight the importance of controlling intestinal flora using probiotics or antibiotics.
format Online
Article
Text
id pubmed-7313056
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73130562020-06-29 Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia Fujiwara-Tani, Rina Fujii, Kiyomu Mori, Shiori Kishi, Shingo Sasaki, Takamitsu Ohmori, Hitoshi Nakashima, Chie Kawahara, Isao Nishiguchi, Yukiko Mori, Takuya Sho, Masayuki Kondoh, Masuo Luo, Yi Kuniyasu, Hiroki Int J Mol Sci Article Sessile serrated adenoma/polyp with dysplasia (SSA/P-D) is an SSA/P with cellular dysplasia and has a higher risk of progressing to colon carcinogenesis. Previously, we reported that tight junction impairment by Clostridium perfringens enterotoxin (CPE) leads to activation of the transcriptional co-activator yes-associated protein (YAP) in oral squamous cell carcinoma. Here, we investigated whether CPE activates YAP to promote the malignant progression of SSA/P. E-cadherin expression was lower in the 12 cases with SSA/P-D examined than that in normal mucosa, SSA/P, or tubular adenoma (TA). Furthermore, intracellular translocation of claudin-4 (CLDN4) and nuclear translocation of YAP were observed. The CPE gene was detected in DNA extracted from SSA/P-D lesions, but not in SSA/P or TA. Treatment of the rat intestinal epithelial cell line IEC6 with low-dose CPE resulted in intracellular translocation of CLDN4 to the cytoplasmic membrane. Cytoplasmic CLDN4 showed co-precipitation with transcriptional co-activator with PDZ-binding motif, zonula occludens (ZO)-1, large tumor suppressor, and mammalian Ste20-like. Additionally, YAP co-precipitated with ZO-2 under CPE treatment led to decreased YAP phosphorylation and nuclear translocation. YAP activation promoted increase in nuclear TEA domain family member level, expression of cyclin D1, snail, vimentin, CD44, NS and decrease in E-cadherin levels, thereby inducing stemness and epithelial-mesenchymal-transition (EMT). The Hippo complex with the incorporation of CLDN4 increased stability. Upon low-dose CPE treatment, HT29 cells with BRAF(V600E) gene mutation showed increased growth, enhanced invasive potential, stemness, and induced EMT phenotype, whereas HCT116 cells, which carry KRAS(G13D) gene mutation, did not show such changes. In an examination of 10 colorectal cancers, an increase in EMT and stemness was observed in CPE (+) and BRAF mutation (+) cases. These findings suggest that C. perfringens might enhance the malignant transformation of SSA/P-D via YAP activation. Our findings further highlight the importance of controlling intestinal flora using probiotics or antibiotics. MDPI 2020-05-28 /pmc/articles/PMC7313056/ /pubmed/32481659 http://dx.doi.org/10.3390/ijms21113840 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fujiwara-Tani, Rina
Fujii, Kiyomu
Mori, Shiori
Kishi, Shingo
Sasaki, Takamitsu
Ohmori, Hitoshi
Nakashima, Chie
Kawahara, Isao
Nishiguchi, Yukiko
Mori, Takuya
Sho, Masayuki
Kondoh, Masuo
Luo, Yi
Kuniyasu, Hiroki
Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
title Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
title_full Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
title_fullStr Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
title_full_unstemmed Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
title_short Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/Polyps with Dysplasia
title_sort role of clostridium perfringens enterotoxin on yap activation in colonic sessile serrated adenoma/polyps with dysplasia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313056/
https://www.ncbi.nlm.nih.gov/pubmed/32481659
http://dx.doi.org/10.3390/ijms21113840
work_keys_str_mv AT fujiwaratanirina roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT fujiikiyomu roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT morishiori roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT kishishingo roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT sasakitakamitsu roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT ohmorihitoshi roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT nakashimachie roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT kawaharaisao roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT nishiguchiyukiko roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT moritakuya roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT shomasayuki roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT kondohmasuo roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT luoyi roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia
AT kuniyasuhiroki roleofclostridiumperfringensenterotoxinonyapactivationincolonicsessileserratedadenomapolypswithdysplasia